$25.62-0.39|(-1.50%)
52W H: 40.2252W L: 20.32Beta: 1.36

About Stoke Therapeutics Inc

Frequently Asked Questions

What is the 52-week range for STOK?

The 52-week high is $40.22 and the 52-week low is $20.32.

What is the P/E ratio for STOK?

The P/E ratio data is currently unavailable.

What is the dividend yield for STOK?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -59.36%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is -753.60%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 5.14.

Analyst Recommendation Trends

Wall Street analyst consensus for STOK over the last few months:

2026-09-01
Buy: 11
S.Buy: 8
Hold: 1
Sell: 0
2026-08-01
Buy: 10
S.Buy: 8
Hold: 1
Sell: 0
2026-07-01
Buy: 9
S.Buy: 8
Hold: 1
Sell: 0
2026-06-01
Buy: 9
S.Buy: 8
Hold: 1
Sell: 0

Latest STOK News

Stoke Therapeutics Appoints Bo Cumbo to its Board of Directors, Enhancing Commercial Expertise as the Company Advances Zorevunersen Development Toward Potential FDA Approval and Commercialization

BEDFORD, Mass., September 23, 2026--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced the appointment of Bo Cumbo to its Board of Directors. Concurrent with Mr. Cumbo’s appointment, Edward Kaye, M.D., has retir

Yahoo9/23/2026

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BEDFORD, Mass., September 16, 2026--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on September 15, 2026, it granted stock options to purchase an aggregate of 53,175 shares of common stock to

Yahoo9/16/2026

Stoke, Biogen Report Lasting Seizure Reductions In Dravet Syndrome Study

Stoke Therapeutics, Inc. (NASDAQ:STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, and Biogen Inc. (NASDAQ:BIIB) today announced presentations

Benzinga9/4/2026

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

–4-year data from the Phase 1/2a open-label extension (OLE) studies showed substantial and durable reductions in seizures and continuing improvements in cognition and behavior in patients treated with zorevunersen on top of standard of care anti-seizure medicines– –New data showed substantial reductions in the most severe seizure types, the leading risk factor for sudden unexpected death in epilepsy (SUDEP)– –Improvements in quality of life were demonstrated through 28 months of treatment– –Zore

Yahoo9/3/2026

Related Stocks (Peers)

Companies operating in similar sectors to STOK:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-09-23Cumbo Alexander+39,674--
2026-09-01Ticho Barry-1,600$31.0569$49,691
2026-09-01Ticho Barry-3,945$30.512$120,370
2026-08-18Allan Jonathan-145$32.4681$4,708
2026-08-18Allan Jonathan-2,716$32.0072$86,932
2026-08-18Ticho Barry-242$32.4681$7,857
2026-08-18Ticho Barry-4,525$32.0072$144,833
2026-08-18Kaye Edward M. MD-637$32.4681$20,682
2026-08-18Kaye Edward M. MD-11,930$32.0072$381,846
2026-08-14Allan Jonathan-6,000--
2026-08-14Allan Jonathan+6,000--
2026-08-14Ticho Barry-10,000--
2026-08-14Ticho Barry+10,000--
2026-08-14Kaye Edward M. MD-26,250--
2026-08-14Kaye Edward M. MD+26,250--
2026-08-03Ticho Barry-1,269$29.4539$37,377
2026-08-03Ticho Barry-5,907$28.9501$171,008
2026-07-16Harrison Seth Loring+17,786--
2026-07-16Harrison Seth Loring-17,786--
2026-07-16Harrison Seth Loring+29,747--
2026-07-16Harrison Seth Loring-29,747--
2026-07-16Harrison Seth Loring+7,639--
2026-07-16Harrison Seth Loring-7,639--
2026-07-16Harrison Seth Loring+19,441--
2026-07-16Harrison Seth Loring-19,441--
2026-07-16Harrison Seth Loring+21,000--
2026-07-16Harrison Seth Loring-21,000--
2026-07-16Harrison Seth Loring+11,650--
2026-07-16Harrison Seth Loring-11,650--
2026-07-16Harrison Seth Loring+14,777--
2026-07-16Harrison Seth Loring-14,777--
2026-07-16Harrison Seth Loring+29,555--
2026-07-16Harrison Seth Loring-29,555--
2026-07-15McCauley Thomas+225,000--
2026-07-01Ticho Barry-500$33.2678$16,634
2026-07-01Ticho Barry-6,728$32.615$219,434
2026-06-16Allan Jonathan-1,457$29.95$43,637
2026-06-03Krainer Adrian R.+17,786--
2026-06-03Burstein Jennifer+17,786--
2026-06-03TZIANABOS ARTHUR+17,786--
2026-06-03Smith Julie+17,786--
2026-06-03Kaye Edward M. MD+17,786--
2026-06-03Harrison Seth Loring+17,786--
2026-06-03LEVIN ARTHUR A+17,786--
2026-06-01Ticho Barry-1,795$30.58$54,891
2026-05-01Ticho Barry-2,243$32.79$73,548
2026-04-03Kahn Clare+30,782--
2026-04-01Ticho Barry-1,838$32.66$60,029
2026-03-20Allan Jonathan-601$34.4079$20,679
2026-03-20Allan Jonathan-8,692$33.6354$292,359
2026-03-19Ticho Barry-1,365--
2026-03-19Ticho Barry-1,461$29.99$43,815
2026-03-19Ticho Barry+1,365$2.19$2,989
2026-03-18Allan Jonathan-72$32.85$2,365
2026-03-18Allan Jonathan-334$31.7888$10,617
2026-03-18Allan Jonathan-4,222$31.2838$132,080
2026-03-18Ticho Barry-103$32.85$3,384
2026-03-18Ticho Barry-483$31.7888$15,354
2026-03-18Ticho Barry-6,100$31.2838$190,831
2026-03-18Leggett Thomas-37$32.85$1,215
2026-03-18Leggett Thomas-172$31.7888$5,468
2026-03-18Leggett Thomas-2,173$31.2838$67,980
2026-03-18Hoitt Jason-30$32.85$986
2026-03-18Hoitt Jason-139$31.7888$4,419
2026-03-18Hoitt Jason-1,762$31.2838$55,122
2026-03-17Allan Jonathan-1,791$33.3754$59,775
2026-03-17Allan Jonathan-2,476$32.7394$81,063
2026-03-17Ticho Barry-2,587$33.3754$86,342
2026-03-17Ticho Barry-3,577$32.7394$117,109
2026-03-17Leggett Thomas-922$33.3754$30,772
2026-03-17Leggett Thomas-1,274$32.7394$41,710
2026-03-17Hoitt Jason-748$33.3754$24,965
2026-03-17Hoitt Jason-1,033$32.7394$33,820
2026-03-15Allan Jonathan-12,000--
2026-03-15Allan Jonathan-6,000--
2026-03-15Allan Jonathan-7,475--
2026-03-15Allan Jonathan+12,000--
2026-03-15Allan Jonathan+6,000--
2026-03-15Allan Jonathan+7,475--
2026-03-15Ticho Barry-10,750--
2026-03-15Ticho Barry-10,000--
2026-03-15Ticho Barry-13,100--
2026-03-15Ticho Barry+10,750--
2026-03-15Ticho Barry+10,000--
2026-03-15Ticho Barry+13,100--
2026-03-15Leggett Thomas-14,750--
2026-03-15Leggett Thomas+14,750--
2026-03-15Hoitt Jason-10,000--
2026-03-15Hoitt Jason+10,000--
2026-03-15Kaye Edward M. MD-26,250--
2026-03-15Kaye Edward M. MD-35,500--
2026-03-15Kaye Edward M. MD+26,250--
2026-03-15Kaye Edward M. MD+35,500--
2026-03-13LEVIN ARTHUR A-605$36.8$22,264
2026-03-10Krainer Adrian R.-33,243$39.7366$1,320,964
2026-03-10TZIANABOS ARTHUR-3,955--
2026-03-10TZIANABOS ARTHUR-4,355$40.0033$174,214
2026-03-10TZIANABOS ARTHUR+3,955$8.33$32,945
2026-03-02Krainer Adrian R.-7,229$39.6618$286,715
2026-02-17Allan Jonathan+35,000--
2026-02-17Allan Jonathan+53,000--
2026-02-17Ticho Barry+40,000--
2026-02-17Ticho Barry+60,000--
2026-02-17Leggett Thomas+40,000--
2026-02-17Leggett Thomas+60,000--
2026-02-17Hoitt Jason+48,000--
2026-02-17Hoitt Jason+72,000--
2026-02-17SMITH IAN F+129,000--
2026-02-17SMITH IAN F+193,000--
2025-12-31LEVIN ARTHUR A-1,211--
2025-12-31LEVIN ARTHUR A+1,211--
2025-12-08Allan Jonathan-2,678$32.6128$87,337
2025-12-08Allan Jonathan-1,300$31.5956$41,074
2025-12-08Kaye Edward M. MD-1,331$33.1041$44,062
2025-12-08Kaye Edward M. MD-8,274$32.52$269,070
2025-12-08Kaye Edward M. MD-3,825$31.4387$120,253
2025-12-05Allan Jonathan-2,344$31.7597$74,445
2025-12-05Allan Jonathan-5,437$31.0828$168,997
2025-12-05Allan Jonathan-1,004$31.3304$31,456
2025-12-05Ticho Barry-1,989$31.3453$62,346
2025-12-05Ticho Barry-1,673$31.3304$52,416
2025-12-05Kaye Edward M. MD-500$31.846$15,923
2025-12-05Kaye Edward M. MD-1,681$31.1468$52,358
2025-12-05Kaye Edward M. MD-6,367$31.3304$199,481
2025-12-04Allan Jonathan-194$31.3164$6,075
2025-12-04Allan Jonathan-824$30.7635$25,349
2025-12-04Ticho Barry-323$31.3164$10,115
2025-12-04Ticho Barry-1,373$30.7635$42,238
2025-12-04Kaye Edward M. MD-1,231$31.3164$38,550
2025-12-04Kaye Edward M. MD-5,222$30.7635$160,647
2025-12-03Allan Jonathan-1,394$30.8477$43,002
2025-12-03Allan Jonathan-898$30.338$27,244
2025-12-03Ticho Barry-1,225$30.8477$37,788
2025-12-03Ticho Barry-789$30.338$23,937
2025-12-03Kaye Edward M. MD-651$30.8477$20,082
2025-12-03Kaye Edward M. MD-419$30.338$12,712
2025-12-03Allan Jonathan-6,000--
2025-12-03Allan Jonathan+6,000--
2025-12-03Ticho Barry-10,000--
2025-12-03Ticho Barry+10,000--
2025-12-03Kaye Edward M. MD-26,250--
2025-12-03Kaye Edward M. MD+26,250--
2025-12-02Allan Jonathan-868$30.1419$26,163
2025-12-02Allan Jonathan-1,416$29.562$41,860
2025-12-02Ticho Barry-762$30.1419$22,968
2025-12-02Ticho Barry-1,244$29.562$36,775
2025-12-02Kaye Edward M. MD-405$30.1419$12,207
2025-12-02Kaye Edward M. MD-661$29.562$19,540
2025-12-01Allan Jonathan-12,357--
2025-12-01Allan Jonathan+12,357--
2025-12-01Ticho Barry-11,981--
2025-12-01Ticho Barry+11,981--
2025-12-01Kaye Edward M. MD-4,317--
2025-11-24Krainer Adrian R.-40,472$29.7173$1,202,719
2025-11-14Krainer Adrian R.-20,682$27.3361$565,365
2025-11-14Krainer Adrian R.-19,790$26.6141$526,693
2025-11-03Ticho Barry-100$29.35$2,935
2025-11-03Ticho Barry-600$27.54$16,524
2025-11-03Ticho Barry-1,455$26.0206$37,860
2025-11-03Ticho Barry-3,776$25.2242$95,247
2025-10-08SMITH IAN F+380,000--
2025-10-08SMITH IAN F+570,000--
2025-10-08Kaye Edward M. MD-25,000--
2025-10-08Kaye Edward M. MD-25,000$30$750,000
2025-10-08Kaye Edward M. MD+25,000$0.6$15,000
2025-10-03Allan Jonathan-10,000--
2025-10-03Allan Jonathan-10,000$25.065$250,650
2025-10-03Allan Jonathan+10,000$9.15$91,500
2025-10-03Kaye Edward M. MD-42,461$25.0867$1,065,206